(Q39691295)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Chao-Liang Wu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Huei-Jiun Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Chi-Chen Lin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Chiu-Mei Lin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Yi-Ling Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Tzu-Yang Weng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Tzu-Ting Huang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Ming-Derg Lai

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

1 reference

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

Experimental Biology and Medicine

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

869-876

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20558841%20AND%20SRC:MED&resulttype=core&format=json

Sirtuins: critical regulators at the crossroads between cancer and aging

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Reconstructing eukaryotic NAD metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Inhibition of indoleamine 2,3-dioxygenase activity in IFN-gamma stimulated astroglioma cells decreases intracellular NAD levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Antisense oligonucleotides and all-trans retinoic acid have a synergistic anti-tumor effect on oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

The role of myeloid cells in the promotion of tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

Monocyte/macrophage infiltration in tumors: modulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001

The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010001